Neurodevelopmental origin of cognitive impairment in schizophrenia

被引:101
|
作者
Bora, E. [1 ,2 ]
机构
[1] Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Melbourne, Vic 3010, Australia
[2] Melbourne Hlth, Melbourne, Vic, Australia
关键词
Cognition; cognitive reserve; neurodevelopment; psychosis; schizophrenia; METABOLIC SYNDROME; NEGATIVE SYMPTOMS; 1ST-EPISODE SCHIZOPHRENIA; EXECUTIVE FUNCTIONS; POSTONSET PERIOD; OLDER-ADULTS; DEFICITS; CHILDHOOD; PSYCHOSIS; RESERVE;
D O I
10.1017/S0033291714001263
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Cognitive impairment is a common feature of schizophrenia; however, its origin remains controversial. Neurodevelopmental abnormalities clearly play a role in pre-morbid cognitive dysfunction in schizophrenia, yet many authors believe that schizophrenia is characterized by illness-related cognitive decline before and after onset of the psychosis that can be the result of neurodegenerative changes. The main reasons behinds such arguments include, first, the evidence showing that effect sizes of the cognitive deficits in subjects who develop adult schizophrenia gradually increase in the first two decades of life and, second, the fact that there is functional decline in many patients with schizophrenia over the years. In this Editorial, I argue that current evidence suggests that illness-related cognitive impairment is neurodevelopmental in origin and characterized by slower gain (developmental lag) but not cognitive decline continuing throughout the first two decades of life. I introduce a model suggesting that neurodevelopmental abnormality can in fact explain the course of cognitive dysfunction and variations in the trajectory of functional decline throughout the life in individuals with schizophrenia. In this model, the severity of underlying neurodevelopmental abnormality determines the age that cognitive deficits first become apparent and contributes to the cognitive reserve of the individual. Interaction of neurodevelopmental abnormality with clinical symptoms, especially negative symptoms and aging, vascular changes, psychological and iatrogenic factors contributes to the heterogeneity of the functional trajectory observed in this disorder.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [21] Cognitive impairment in the schizophrenia spectrum: exploring the relationships of the g-factor with sociodemography, psychopathology, neurodevelopment, and genetics
    Yeh, Delphine
    He, Qin
    Krebs, Emma
    Iftimovici, Anton
    Martinez, Gilles
    Bourgin-Duchesnay, Julie
    Mouaffak, Faycal
    Danset-Alexandre, Charlotte
    de Gasquet, Marie
    Jantac, Celia
    Bendjemaa, Narjes
    Chaumette, Boris
    Krebs, Marie-Odile
    Scoriels, Linda
    PSYCHOLOGICAL MEDICINE, 2024, 54 (15) : 4243 - 4254
  • [22] THE COST OF COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA
    SEVY, S
    DAVIDSON, M
    SCHIZOPHRENIA RESEARCH, 1995, 17 (01) : 1 - 3
  • [23] Shared and distinct gray matter abnormalities in schizophrenia, schizophrenia relatives and bipolar disorder in association with cognitive impairment
    Knoechel, Christian
    Staeblein, Michael
    Prvulovic, David
    Ghinea, Denisa
    Wenzler, Sofia
    Pantel, Johannes
    Alves, Gilberto
    Linden, David E. J.
    Harrison, Octavia
    Carvalho, Andre
    Reif, Andreas
    Oertel-Knoechel, Viola
    SCHIZOPHRENIA RESEARCH, 2016, 171 (1-3) : 140 - 148
  • [24] Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia
    Sumiyoshi, Tomiki
    Kunugi, Hiroshi
    Nakagome, Kazuyuki
    FRONTIERS IN NEUROSCIENCE, 2014, 8
  • [25] Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment
    McCleery, A.
    Ventura, J.
    Kern, R. S.
    Subotnik, K. L.
    Gretchen-Doorly, D.
    Green, M. F.
    Hellemann, G. S.
    Nuechterlein, K. H.
    SCHIZOPHRENIA RESEARCH, 2014, 157 (1-3) : 33 - 39
  • [26] Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis
    Tanzer, Timothy
    Shah, Shelukumar
    Benson, Catherine
    De Monte, Veronica
    Gore-Jones, Victoria
    Rossell, Susan L.
    Dark, Frances
    Kisely, Steve
    Siskind, Dan
    Melo, Catarina Drumonde
    PSYCHOPHARMACOLOGY, 2020, 237 (01) : 11 - 19
  • [27] Differences in cognitive impairment between schizophrenia and bipolar disorder: Considering the role of heterogeneity
    Bora, Emre
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2016, 70 (10) : 424 - 433
  • [28] Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia
    Wang, M. Y.
    Ho, N. F.
    Sum, M. Y.
    Collinson, S. L.
    Sim, K.
    SCHIZOPHRENIA RESEARCH, 2016, 175 (1-3) : 97 - 102
  • [29] Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment
    Javitt, Daniel C.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2023, 63 : 119 - 141
  • [30] Mitochondrial Dysfunction and Cognitive Impairment in Schizophrenia: The Role of Inflammation
    Wang, Guanyu
    Liu, Senqi
    Fan, Xiaoyun
    Li, Jinming
    Xue, Qianzi
    Liu, Kang
    Li, Xue
    Yang, Yongfeng
    Wang, Xiujuan
    Song, Meng
    Shao, Minglong
    Li, Wenqiang
    Han, Yong
    Lv, Luxian
    Su, Xi
    SCHIZOPHRENIA BULLETIN, 2024,